Lyra Therapeutics, Inc. (LYRA)

Accolade Revenue

Lyra Therapeutics had revenue of $183.00K in the quarter ending March 31, 2025, a decrease of -65.60%. This brings the company's revenue in the last twelve months to $1.19M, down -29.46% year-over-year. In the year 2024, Lyra Therapeutics had annual revenue of $1.53M, down -1.54%.

• Revenue (ttm): $1.19M
• Revenue Growth: -29.46%
• P/S Ratio: 7.56
• Revenue / Employee: $39,500
• Employees: 30
• Market Cap: 10.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.53M	-24.00K	-1.54%
Dec 31, 2023	1.56M	195.00K	14.31%
Dec 31, 2022	1.36M	1.08M	378.25%
Dec 31, 2021	285.00K	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.